Persistent anticipatory nausea, vomiting, and anxiety in cured Hodgkin's disease patients after completion of chemotherapy.
Six to 140 months after completion of chemotherapy, 63% of 60 Hodgkin's disease survivors experienced anticipatory nausea, 80% had anxiety, and 5% reported vomiting. Time since treatment and treatment severity were significantly associated with pervasiveness of nausea but not of anxiety.
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001007:Anxiety / Q000209:etiology* / Q000523:psychology; D003214:Conditioning, Classical; D003463:Cues; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000209:etiology* / Q000523:psychology; D012677:Sensation; D013997:Time Factors; D014839:Vomiting / Q000209:etiology* / Q000523:psychology